NEUEHEALTH INC (NEUE) Stock Analyst Ratings
USA - NYSE:NEUE - US10920V4041 - Common Stock
6.753 USD
+0.08 (+1.24%)
6.73 USD
-0.02 (-0.34%)
ChartMill assigns a Buy % Consensus number of 43% to NEUE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 5.73% above the current price.
NEUE was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NEUE.
In the previous month the buy percentage consensus was at a similar level.
NEUE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-09 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-03-13 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
NEUEHEALTH INC / NEUE FAQ
What do analysts expect the price target to be for NEUEHEALTH INC (NEUE)?
7 analysts have analysed NEUE and the average price target is 7.14 USD. This implies a price increase of 5.73% is expected in the next year compared to the current price of 6.753.
What is the consensus rating for NEUE stock?
The consensus rating for NEUEHEALTH INC (NEUE) is 42.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.